IFNG and Miyoshi myopathy: Another study evaluated ICD induced by bortezomib in MM cell lines and MM primary cells, as well as the capacity of bortezomib-treated cells to increase maturation markers in DCs and to induce proliferation and polarization toward IFN-γ producing T cells in vitro (Spisek et al., 2007).